Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder
Clinical trial registration, sponsored by University of Chicago, registered 1 Jun 2022.
Phase 2 · completed · n = 10
Tags: Registry, Psilocybin, Depression.
Results posted for a University of Chicago study of psilocybin in co-occurring major depression and borderline personality disorder
How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)
Read the original
